An early phase II study of oral S-1, a newly developed 5-fluorouracil derivative for advanced and recurrent gastrointestinal cancers. The S-1 Gastrointestinal Cancer Study Group (Q73143101)
Jump to navigation
Jump to search
scientific article published on 01 October 1999
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | An early phase II study of oral S-1, a newly developed 5-fluorouracil derivative for advanced and recurrent gastrointestinal cancers. The S-1 Gastrointestinal Cancer Study Group |
scientific article published on 01 October 1999 |
Statements
An early phase II study of oral S-1, a newly developed 5-fluorouracil derivative for advanced and recurrent gastrointestinal cancers. The S-1 Gastrointestinal Cancer Study Group (English)
K Sugimachi
Y Maehara
N Horikoshi
Y Shimada
Y Sakata
Y Mitachi